President Donald Trump will deliver a speech on April 26 focused on ways to lower prescription drug prices, but the pharmaceutical industry doesn’t expect it to include the more dramatic reforms Trump espoused on the campaign trail.
MRI might be best used as a critical diagnostic tool for radiologists, but outside of the specialty, researchers have used the powerful machines to image patients’ brains while they do things from play video games to sing opera.
The American Board of Radiology (ABR) made significant changes to its certification program for diagnostic radiologists in recent years, removing the oral component of the exam and relying on a standardized format with multiple-choice questions. This shift toward psychometric testing has made the certification program less reliable, according to a new analysis published by the Journal of the American College of Radiology, and the ABR should consider working with various stakeholders and education experts to change it.
An old McDonald's-turned-MRI center doesn't sound all that important, but for pathologist Robert Kagan, it was a unique location to start practicing medical imaging in one of the first outpatient MRI centers in the U.S.
Amazon has reportedly shelved plans to sell and distribute pharmaceuticals to hospitals and health systems through its Amazon Business unit, a move which analysts said illustrates the difficulty outside companies face in disrupting the existing healthcare supply chain.
According to a survey conducted by Black Book, 91 percent of patients under the age of 50 favored practices that offered exceptional connectivity and patient portals.
Densitas, a medical device company based out of Halifax, Nova Scotia, Canada, announced that DENSITAS|density, its software that uses machine learning to produce breast density reports, has gained FDA clearance.
